SAMINA ASFANDIYAR: Open Payments
NPI 1306496211 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 6 payments from 6 companies in 2025. Trend: 2023 $2,253 · 2024 $2,530 · 2025 $428
Food & beverage: $348Education: $80
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 1 | $116 |
| Tandem Diabetes Care, Inc. | 1 | $108 |
| Astellas Pharma US Inc | 1 | $80 |
| Merck Sharp & Dohme LLC | 1 | $70 |
| Deciphera Pharmaceuticals Inc. | 1 | $31 |
| Incyte Corporation | 1 | $23 |
Products named: OMNIPOD, t:slim X2 Insulin Pump with Control-IQ, KEYTRUDA, QINLOCK, Jakafi.
Industry payments across TX — which companies pay providers there.
